DNDi and Abbott Expand Partnership to Boost Innovation for Neglected Tropical Diseases
01-Feb-2012 -
The Drugs for Neglected Diseases initiative (DNDi) and Abbott have signed a four-year joint research and non-exclusive licensing agreement to undertake research on new treatments for several of the world's most neglected tropical diseases, including Chagas disease, helminth infections, ...
Abbott
Chagas disease
leishmaniasis
+1